PMID: 6170284Nov 1, 1981Paper

Mediastinal dissection. A multi-institutional assessment

Archives of Otolaryngology
D E SchullerJ L Gluckman

Abstract

Mediastinal dissection was first described by George A. Sisson, MD, in 1962. However, there are no other reports in the literature describing the experience of other surgeons with this procedure. This study retrospectively analyzes the multi-institutional experience with mediastinal dissection to examine critically its effectiveness in controlling superior mediastinal neoplastic disease and to evaluate the complications of the procedure. This article describes 21 patients from three medical centers who have undergone mediastinal dissection by three surgeons for stomal recurrences. There are six patients who are free of disease for periods ranging from three months to six years postoperatively. Reconstructive techniques ranged from deltopectoral flap, gastric pull-up, or jejunal free grafts for esophageal reconstruction, myocutaneous flaps for tracheal reconstruction, to deltopectoral or thoracoacromial skin flaps for external resurfacing. This article also describes modifications designed to decrease mortality and to expedite the reconstruction, considering that this series suggests that mediastinal dissection probably should be considered as a palliative rather than curative attempt.

Citations

Jan 1, 1996·Head & Neck·X LeónL de Andrés
Aug 1, 2013·ORL; Journal for Oto-rhino-laryngology and Its Related Specialties·Jie LiuZhengang Xu
Dec 21, 2017·International Journal of Endocrinology·Ting-Ting ZhangQing-Hai Ji
Mar 25, 2009·American Journal of Clinical Oncology·Houyu ZhaoShixi Liu
Sep 1, 1995·Head & Neck·M K WaxG Graeber
Nov 1, 1990·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·J RubinE N Myers
Jan 1, 1993·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·R S WeberH Goepfert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.